A. Coates
University of North Carolina at Chapel Hill · 19 works · 1,632 citations · h-index 9
Top works
- Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
- Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer
- A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer
- Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer
- Recombinant Fibrinogen Vlissingen/Frankfurt IV
- Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure
- The impaired polymerization of fibrinogen Longmont (Bβ166Arg→Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers
- An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors
- Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC)
- Fibrinogen Longmont
- Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.
- Phase I results of ABT-751, a novel microtubulin inhibitor, administered daily × 7 every 3 weeks
- Dependence of heme accessibility in horseradish peroxidase on Ca2+
- Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC)
- P2-251: Phase 1/2 study evaluating the safety and efficacy of ABT-751 in combination with docetaxel vs docetaxel alone in subjects with advanced or metastatic non-small-cell lung cancer
- P2-175: Phase 1/2 trial of ABT-751 in combination with pemetrexed vs pemetrexed alone in subjects with advanced or metastatic non-small-cell lung cancer (NSCLC)
- Randomized P hase I II S tudy o f T emozolomide V ersus Dacarbazine i n t he T reatment o f P atients W ith A dvanced Metastatic M alignant M elanoma
- PD-077 Preliminary survival estimates in a Phase 2 study of ABT-751 in patients with taxane-refractory non-small cell lung carcinoma
- Recombinant Fibrinogen Vlissingen/Frankfurt IV: THE DELETION OF RESIDUES 319 AND 320 FROM THE γ CHAIN OF FIBRINOGEN ALTERS CALCIUM BINDING, FIBRIN POLYMERIZATION, CROSS-LINKING, AND PLATELET AGGREGATION